Search All News
Columbia researchers have identified a gene signature in localized prostate cancer that predicts the cancer’s odds of spreading and its response to a common treatment for advanced disease.
Leaders in prostate cancer research and care will convene Sept. 22 for the inaugural NYC Prostate Cancer Summit, a patient-focused event co-hosted by CUIMC and NewYork-Presbyterian.
Researchers discovered a mechanism that reprograms tumor cells in patients with advanced prostate cancer, reducing their response to anti-androgen therapy.
An experimental urine test that detects genetic changes associated with prostate cancer identified 92 percent of men with elevated PSA levels who had more aggressive disease.
- May 12, 2014
Two genes together drive the most lethal forms of prostate cancer; could lead to diagnostic test and new treatments.
- October 31, 2013
Utilizing the latest techniques in molecular biology and genetics, the married team of Cory Abate-Shen and Michael Shen are tackling metastatic prostate cancer.
- September 11, 2013
A new genetic test may help determine which men with early prostate cancer can avoid surgery or other invasive treatment.
- April 23, 2013
A study from Columbia University’s Mailman School of Public Health is one of the first assessments of the link between obesity and precancerous abnormalities in biopsy tissue samples.
- August 9, 2010
Pilot Study by Columbia University Medical Center Urologic Surgeons Reports on Technology's Potential
- October 6, 2004